Investigator
Simon W Hayward
ENDEAVOR HEALTH CLINICAL OPERATIONS · funded by NIDDK
- Companies
- 4
- Grants
- 5
- Non-dilutive funding
- $1.6M
- First award
- Aug 15, 2023
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Aug 1, 2024.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- ENDEAVOR HEALTH CLINICAL OPERATIONSMomentum in another area
ImmunologyGrant-only
- ENDEAVOR HEALTH CLINICAL OPERATIONSMomentum in another area
ImmunologyGrant-only
- ENDEAVOR HEALTH CLINICAL OPERATIONSMomentum in another area
ImmunologyGrant-only
- ENDEAVOR HEALTH CLINICAL OPERATIONSMomentum in another area
ImmunologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- P20
Validating Mouse Models of Prostatic Hyperplasia
$41kAug 1, 2024NIDDKENDEAVOR HEALTH CLINICAL OPERATIONSNIH RePORTER · 11145144 (opens the source filing in a new tab)
- P20
Validating Mouse Models of Prostatic Hyperplasia
$388kAug 1, 2024NIDDKENDEAVOR HEALTH CLINICAL OPERATIONSNIH RePORTER · 11145116 (opens the source filing in a new tab)
- P20
Validating Mouse Models of Prostatic Hyperplasia
$380kAug 1, 2024NIDDKENDEAVOR HEALTH CLINICAL OPERATIONSNIH RePORTER · 11323197 (opens the source filing in a new tab)
- P20
Validating Mouse Models of Prostatic Hyperplasia
$41kAug 1, 2024NIDDKENDEAVOR HEALTH CLINICAL OPERATIONSNIH RePORTER · 11323198 (opens the source filing in a new tab)
- R01
Effects of TNF Blockade on Human BPH/LUTS
$712kAug 15, 2023NIDDKENDEAVOR HEALTH CLINICAL OPERATIONSNIH RePORTER · 11163248 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources